ARCT
Arcturus Therapeutics Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.68
-0.32 ▼ -4.57%
🌙 3월 13일 7:26 PM ET (한국 3/14 08:26)
$6.82
+0.14 ▲ +2.10%
| Index | RUT | P/E | - | EPS (ttm) | -2.39 | Insider Own | 8.43% | Shs Outstand | 0.03B | Perf Week | -6.05% |
| Market Cap | 0.19B | Forward P/E | - | EPS next Y | -3.58% | Insider Trans | - | Shs Float | 0.03B | Perf Month | -9.73% |
| Enterprise Value | -0.02B | PEG | - | EPS next Q | -1 | Inst Own | 77.01% | Short Float | 23.36% | Perf Quarter | -12.91% |
| Income | -0.07B | P/S | 2.82 | EPS this Y | -66.53% | Inst Trans | -8.63% | Short Ratio | 11.96 | Perf Half Y | -62.97% |
| Sales | 0.07B | P/B | 0.89 | EPS next 5Y | 26.32% | ROA | -21.39% | Short Interest | 6.08M | Perf YTD | 8.97% |
| Book/sh | 7.53 | P/C | 0.82 | EPS past 3/5Y | - 7.53% | ROE | -28.92% | 52W High | -72.36% ($24.17) | Perf Year | -51.94% |
| Cash/sh | 8.12 | P/FCF | - | Sales past 3/5Y | -31.15% 47.77% | ROIC | -28.02% | 52W Low | 14.19% ($5.85) | Perf 3Y | -56.93% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 20.51% | Gross Margin | 95.41% | Volatility(W/M) | 6.91% 6.69% | Perf 5Y | -86.5% |
| Dividend TTM | - | EV/Sales | -0.24 | Sales Y/Y TTM | -51.43% | Oper. Margin | -111.51% | ATR (14) | 0.52 | Perf 10Y | -78.93% |
| Dividend Ex-Date | - | Quick Ratio | 6.64 | EPS Q/Q | 6.92% | Profit Margin | -97.86% | RSI (14) | 36.72 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.64 | Sales Q/Q | -85.33% | SMA20 | -12.55% ($7.64) | Beta | 2.5 | Target Price | $23.44 |
| Payout | - | Debt/Eq | 0.12 | Earnings | 3000000 | SMA50 | -9.55% ($7.39) | Rel Volume | 0.89 | Prev Close | $7 |
| Employees | 111 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | -32.58% -54.75% | SMA200 | -43.76% ($11.88) | Avg Volume(3M) | 0.51M | Price | $6.68 |
| IPO | 2013/5/22 | Option/Short | Yes/Yes | Trades | 5425 | Volume | 453,649 | Change | -4.57% |
뉴스 로딩 중...